AstraZeneca Reaches $26M Deal With SC In Seroquel Suit

Law360, New York (August 24, 2012, 9:42 PM EDT) -- AstraZeneca Pharmaceuticals LP on Wednesday reportedly agreed to pay $26 million to settle South Carolina's suit alleging the pharmaceutical giant deceptively marketed its multibillion-dollar antipsychotic drug Seroquel.

Under the terms of the settlement, AstraZeneca agreed to pay $20 million in damages and restitution to the state, $5 million in penalties and $1 million in costs, according to a report Thursday by the Spartanburg Herald-Journal.

The case was first filed Jan. 9 by the attorney general of South Carolina, seeking to recover funds the state spent on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.